
Sign up to save your podcasts
Or


Tom is joined by Sam Chang, Sia Daneshmand, and Petros Grivas to discuss new therapies in non-muscle invasive bladder cancer, including those for BCG-refractory NMIBC and the cretostimogene + pembrolizumab combo for BCG-unresponsive NMIBC.
By The Uromigos4.9
5757 ratings
Tom is joined by Sam Chang, Sia Daneshmand, and Petros Grivas to discuss new therapies in non-muscle invasive bladder cancer, including those for BCG-refractory NMIBC and the cretostimogene + pembrolizumab combo for BCG-unresponsive NMIBC.

21,972 Listeners

32,271 Listeners

30,731 Listeners

502 Listeners

1,304 Listeners

15 Listeners

59 Listeners

8,760 Listeners

23 Listeners

2 Listeners

61 Listeners

2,054 Listeners

2,144 Listeners

197 Listeners

46 Listeners